Cancer immunotherapy has long struggled with a fundamental problem: the immune cells best equipped to destroy tumors tend to burn out before the job is done. That biological failure point is now better understood.
Researchers from the Salk Institute for Biological Studies, UNC Lineberger Comprehensive Cancer Center, and UC San Diego have identified genetic mechanisms that determine whether CD8 “killer” T cells become durable defenders or slide into a weakened, ineffective state known as exhaustion. The study, published in Nature, found that disabling just two specific genes restored the tumor-killing capacity of exhausted T cells — without stripping away their ability to provide long-term immune memory.
Mapping the Spectrum of Immune Cell States
Protective and exhausted T cells can look nearly identical under traditional analysis. To cut through that ambiguity, the research team constructed a detailed genetic atlas of CD8 T cell states, mapping how these cells shift along a spectrum from highly protective to severely impaired.
The atlas involved examining nine distinct CD8 T cell conditions using genetic tools, mouse models, advanced laboratory methods, and computational analysis. That work revealed multiple transcription factors — proteins that regulate gene activity — acting as switches that push T cells toward either sustained function or dysfunction.
“Our long-term goal is to make immune therapies work better by creating clear ‘recipes’ for designing T cells,” said Susan Kaech, PhD, co-corresponding author and professor at the Salk Institute at the time of the study. “By building a comprehensive atlas of CD8 T cell states, we were able to pinpoint the key factors that define protective versus dysfunctional programs — information that is essential for precisely engineering effective immune responses.”
Two Unknown Genes, One Significant Finding
Among the regulators identified, two transcription factors stood out: ZSCAN20 and JDP2. Neither had previously been linked to T cell exhaustion. When the team disabled both genes, exhausted T cells recovered their ability to attack tumors while retaining long-term immune memory — two outcomes that had not previously been shown to coexist after such an intervention.
“We flipped specific genetic switches in the T cells to see if we could restore their tumor-killing function without damaging their ability to provide long-term immune protection,” said co-corresponding author H. Kay Chung, PhD, an assistant professor at UNC Lineberger who began the research at the Salk Institute. “We found that it was indeed possible to separate these two outcomes.”
T cell exhaustion develops when the immune system faces prolonged threats — chronic infections or persistent tumors — causing these cells to gradually lose their effectiveness. The fact that two previously unknown genes appear to govern this process adds a new layer to the existing understanding of immune regulation.
According to the announcement, the research provides a framework that may allow scientists to deliberately program T cells to maintain both strong cancer-fighting activity and lasting immune protection, with potential applications in cancer immunotherapy and treatments for infectious diseases.
This article is a curated summary based on third-party sources. Source: Read the original article
